Latest news: Acute toxicity might predict biochemical control after prostate radiotherapy!

Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy

Information

for Patients

for the Scientific Community

about the Consortium

discover Data

News

REQUITE on Facebook

Acute toxicity might predict biochemical control after prostate radiotherapy!

25th September 2018

The research article: "Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study" from Thomas Eade FRANZCR, Ananya Choudhury MA, PhD, MRCP, FRCR, Alan Pollack MD, PhD, Matthew Abramowitz MD, Felix M. Chinea MD, Linxin Guo BSc, MHSc, Jason Kennedy BSc, MSc, Sandra Louw, George Hruby FRANZCR, Andrew Kneebone FRANZCR, Catharine West PhD, has been published in the International Journal of Radiation Oncology Biology Physics, Volume 101, Issue 4, 15 July 2018, Pages 957-963.

REQUITE Patient Leaflet!

21st September 2018

We are very pleased to show you the REQUITE Patient Leaflet! In this Leaflet we would like to inform you on the progress of this project and to thank all the patients who agreed to take part in the REQUITE study. The Leaflet is available in English, Spanish, French, German, Italian and Dutch. 

Successful Radiogenomics Consortium Meeting and Final Requite Meeting in Manchester

30th August 2018
The 11th annual RGC meeting was held at the Manchester Cancer Research Centre - Manchester’s newest cancer research facility on July 16th, 2018.  The Radiogenomics Consortium members presented the latest developments in the research on genetics of toxicity induced radiotherapy.
  • The first day of the Final REQUITE Symposium (17th July, 8:30-17:30, CityLabs) was open to REQUITE consortium me

Older news

Recruitment

Breast
2071
Lung
559
383*
Prostate
1809
* non-REQUITE patients included in our analyses

Events

ESMO2018 Congress: Securing access to optimal cancer care

ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.

For more information: website

Dates: 
Friday, 19 October, 2018 to Tuesday, 23 October, 2018
Location: 
Messe Munich
Messegelände
81823 München
Germany
See map: Google Maps
DE

ASTRO 2018

ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.

Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018

Dates: 
Sunday, 21 October, 2018 to Wednesday, 24 October, 2018
Location: 
Henry B. Gonzalez Convention Center
900 E Market St
TX 78205 San Antonio
United States
See map: Google Maps
US

ESTRO 38

The annual congress of ESTRO will take place 26-30 April 2019 in Milan, Italy. ESTRO 38 will offer all professionals of oncology the chance to share knowledge, practice and advances in the field, within the ever warm and dynamic environment of the ESTRO meetings. ‘Targeting optimal care, together’ will be the theme of ESTRO 38 and through these few, however impactful words, the Scientific and organising committees would like to put a spotlight on the multiprofessional and multidisciplinary aspect of our specialty. The theme also represents our strength: we are all working towards a common goal for improved patient outcomes, and this will be expressed throughout the scientific programme... See for more information the website

Dates: 
Friday, 26 April, 2019 to Tuesday, 30 April, 2019
Location: 
MiCo (Milano Congressi)
Viale Ludovico Scarampo - Fieramilanocity
20149 Milano
Italy
See map: Google Maps
IT

Languages